Founded in 1992, the Clinical Research Unit's vision was to improve the health of our members, community, and nation through health care and policy research.Renamed to the Institute for Health Research in 2006 the IHR continued this vision via our mission to conduct research that can be translated into clinical practice, health promotion, and policies to influence the health of individuals and populations.
IHR Clinical Trials
In 1998, Clinical Trials started with a small group of employees at various locations. In 2002, a formal Clinical Trials office was established to support the conduct of clinical trials throughout the Colorado region. Clinical Trials continues to grow and now consists of 16 employees, specifically trained and certified in the conduct of clinical trials and is located at the new Midtown Medical Building. The Clinical Trials department works with the National Institutes of Health (NIH) and various pharmaceutical companies to provide clinical trials for our Kaiser Permanente Members. Visit the IHR Clinical Trials website to learn about the research they are doing.
Institutional Review Board (IRB).
The KPCO IRB is responsible for assuring that appropriate measures are followed to protect the rights, safety, and welfare of human research participants. These protections extend to biological specimens (whether collected for research purposes or not) and information about Health Plan members and other research participants, including paper and electronic medical records maintained by KPCO. The IRB must approve all research and research related documents before potential research participants can be contacted about a study and before their Protected Health Information (PHI) can be accessed. The IRB conducts periodic reviews to monitor the progress of the research until the project is concluded.
The KPCO IRB operates in compliance with federal regulations including those promulgated by the U.S. Department of Health and Human Services (DHHS) and U.S. Food and Drug Administration (FDA), as well as in compliance with the Kaiser Permanente (KP) Human Research Participant Protection Program (HRPPP) and the KP Federalwide Assurance (FWA).
The KPCO IRB fulfills these responsibilities by working with researchers to develop appropriately designed studies that assure adequate provisions are taken to protect research participant's well-being, privacy and confidentiality. To this end, while the KPCO IRB recognizes its role in assuring compliance with federal, state and Kaiser Permanente policy, it also strives to be a research partner to conducting exceptional clinical research at this institution.